Figure 4.
Funnel plot to evaluate publication bias for the pooled effect size to determine the rate of mortality associated with TGM/CGM-based treatment in patients at high risk for breakthrough and severe SARS-CoV-2 infection.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.